Navigation Links
JAZZ PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS
Date:8/6/2013

er of 2013 net interest expense was $7.1 million, and the loss on extinguishment and modification of debt was $3.7 million.  As of June 30, 2013, our cash and cash equivalents were $504.3 million, and the balance of our term loans was $552.3 million. The balance of cash and cash equivalents increased from December 31, 2012 primarily due to the cash generated from our business and the net proceeds of the new term loans, offset in part by funds used to repurchase our ordinary shares under our share repurchase program and increases in working capital.

In May 2013, our board of directors authorized the use of up to $200 million to repurchase the company's ordinary shares.  As of June 30, 2013, we had repurchased 846,197 shares for $53.6 million at an average cost of $63.32 per share. 

On June 13, 2013, we amended our credit agreement, increased the principal amount of the term loans to $557.2 million, an increase of $100 million from the remaining principal amount of the original term loans, and increased the revolving credit facility from $100 million to $200 million.  The interest rate on our term loans is currently 3.5% based on a 0.75% LIBOR floor plus a margin of 2.75% per annum, compared to an interest rate of 5.25% prior to the amended credit agreement. Our revolving credit facility remains undrawn.

During the fourth quarter of 2012, the company sold its women's health business.  Financial results from the women's health business are reported as discontinued operations for the 2012 periods.

2013 Financial Guidance Jazz Pharmaceuticals is providing the following updated 2013 guidance:Revenues

 

$860-$880 million

 Total Net Product Sales

 

$853-$873 million

 -Xyrem Net Sales

-Erwinaze/Erwinase Net Sales

$560-$570 million

$170-$180 millionAdjusted Gross Margin %1,3

88-90% Adjusted Combined SG&A an
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Cumberland Pharmaceuticals Reports Second Quarter Financial Results
2. Inovio Pharmaceuticals Responds to Market Activity
3. UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
4. Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch + Lomb
5. Avanir Pharmaceuticals to Participate in Two Conferences in August
6. Imprimis Pharmaceuticals, Inc. to Present at the Southern California Investor Conference on Thursday, August 8, 2013 at the Island Hotel in Newport Beach, CA. The presentation is scheduled to begin at 11 a.m. ET / 8 a.m. PT
7. AcelRx Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference
8. Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
9. Intercept Pharmaceuticals to Present at the Wedbush Securities Life Sciences Management Access Conference
10. GW Pharmaceuticals Announces Results of MS Spasticity Study Confirming Sativex Has No Long-Term Negative Effect on Cognition
11. GW Pharmaceuticals plc Reports 2013 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... France , Dec. 19, 2014  Eli Lilly ... (Euronext Paris: FR0011184241 – ADOC) today announced a worldwide ... as BioChaperone Lispro, for treatment in people with type ... Adocia,s proprietary BioChaperone® technology and is currently in Phase ... BioChaperone Lispro with the goal of optimizing glucose levels ...
(Date:12/17/2014)... 2014 Revenue and earnings above the ... and development In the past 2013/14 fiscal year ... percent to EUR 4.287 billion (last year: EUR 4.190 billion) ... to EUR 360 million. "Overall, 2013/14 was a successful fiscal ... , President and CEO of Carl Zeiss AG. "Thanks to ...
(Date:12/17/2014)... , Dec. 17, 2014  Beamz Interactive, ... interactive music products, today announced that it has ... leading manufacturer and supplier of innovative prosthetic, orthotic ... As part of the agreement, RSL Steeper will ... solution specifically configured for use within UK residential ...
Breaking Medicine Technology:Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3ZEISS Asserts its Position in Difficult Environment 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3
... Sutro Biopharma, a biopharmaceutical company developing both ... properties, today announced that it has appointed Trevor ... Hallam will lead Sutro,s ongoing efforts in the ... platform for the research and development of novel ...
... 8, 2010 /PRNewswire-Asia/ -- From the 1st to the ... developed world will meet at Vaccine World Summit in ... in partnership with DCVMN (Developing Countries Vaccine Manufacturers Network). ... global public health challenges including appropriate pandemic surveillance programs, ...
Cached Medicine Technology:Sutro Biopharma Appoints Trevor Hallam, Ph.D., as Chief Scientific Officer 2World Vaccine Leaders to Meet in New Delhi India to Tackle Global Public Health Challenges 2
(Date:12/20/2014)... December 21, 2014 BambooIndustry.com is ... Recently, the business has announced its bamboo flooring ... the best material from certified suppliers, and offers ... customers worldwide. In the current promotion, all customers ... off, when they say they know BambooIndustry.com from ...
(Date:12/20/2014)... December 20, 2014 Dress company LunaDress has ... and announced its Christmas Sale, offering big discounts on all ... girl has an idea to own a perfect wedding gown. ... your wedding dress, then come to LunaDress. Many different wedding ... you. Visit our website now and enjoy the current special ...
(Date:12/20/2014)... VogueQueen.com, a leading wedding dress wholesaler and retailer, has ... 2015. Great discounts are now offered on all of ... a discount, up to 80% off, when they place ... 2015. , VogueQueen.com has recently released its new arrival ... Many customers worldwide like VogueQueen’s special designs which feature ...
(Date:12/20/2014)... 20, 2014 Atore, Inc, (San Francisco, ... launched first birthday focused portal on December 17th, 2014. ... launched in both US and Japan. , MERRY BIRTHDAY ... http://merrybirthday.net/message/ , MERRY BIRTHDAY MESSAGE is part ... the world. , Features, Choose from thousands of stock ...
(Date:12/20/2014)... Columbus, OH (PRWEB) December 20, 2014 ... contend they suffered uncontrollable bleeding and other ... District Court, Eastern District of Louisiana for coordinated pretrial ... Panel on Multidistrict Litigation (JPML) issued an order Friday ... tag-along actions pending in 22 federal courts to the ...
Breaking Medicine News(10 mins):Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2Health News:VogueQueen Big Sale Online For The Coming 2015 2Health News:Atore, Inc. Releasing the First Birthday Portal 2Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 2Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 3Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 4
... patients could benefit from similar,improvements, DALLAS, ... article published today, "An organized approach to ... presented the first,head-to-head comparison of quality medical ... Disease (GWTG-CAD) hospitals vs. other US,hospitals not ...
... PITTSBURGH, Sept. 8 Mylan Inc. (NYSE: ... to market and other,conditions, $400 million principal amount ... offering to qualified institutional buyers pursuant,to Rule 144A ... (the "Securities,Act"). Mylan also expects to grant the ...
... States Agency for International Development (USAID) has awarded the ... at Chapel Hill up to $181 million to continue ... largest ever received by UNC. , The award funds ... child health, nutrition and HIV/AIDS programs around the world. ...
... Menopausal women who take hormones face greater chance of ... -- Women who take hormones to relieve symptoms of ... gastroesophageal reflux disease (GERD). , Also, women who use ... cancer and osteoporosis, also have a higher risk of ...
... Sept. 8 The nation faces,challenges in utilizing ... health, according to a NASA-sponsored report issued Monday,by ... report examines the computer-based decision support tools that ... in areas such as,agricultural productivity, air quality, renewable ...
... Sunday, Sept 14, 2008, WHERE: Moscone South Convention Center ... Francisco, CA 94103, and, ... 55 4th Street San Francisco, CA 94103, ... Nickols (916) 704-8965, WHAT: Approximately 15,000 dentists and dental professionals are ...
Cached Medicine News:Health News:Hospitals Participating in Get With The Guidelines(SM) Program Follow Heart Attack Treatment Guidelines Better Than Others 2Health News:Mylan to Offer $400 Million in Cash Convertible Notes 2Health News:Mylan to Offer $400 Million in Cash Convertible Notes 3Health News:UNC receives record $181 million grant to evaluate health, poverty and gender programs worldwide 2Health News:HRT Use Raises Risk of Stomach Trouble 2Health News:HRT Use Raises Risk of Stomach Trouble 3Health News:Report Explores Use of Earth Data to Support National Priorities 2Health News:Report Explores Use of Earth Data to Support National Priorities 3Health News:Renowned Dentists to Present Latest on Dental Innovations 2Health News:Renowned Dentists to Present Latest on Dental Innovations 3
... Bledsoe Sport & Sport Max patellofemoral knee ... and/or collateral injuries. Patients with minor knee ... can benefit from added support to prevent ... designs to provide the right kind of ...
... Brace gives fracture treatment patients maximum support ... brace features the the Bledsoe Multi-Centric Hinge, ... and positively locks at any angle within ... slots, the Bledsoe Multi-Centric Hinge anatomically tracks ...
... The Bledsoe Revolution ... for speed fitting under ... frees the surgeon or ... time-consuming post-op fitting and ...
The Bledsoe Post-Op Knee Brace is designed to provide maximum protection without sacrificing comfort and quick, easy application....
Medicine Products: